These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Homologous radioimmunoassay for human parathyrin (residues 53-84). Hitzler W; Schmidt-Gayk H; Spiropoulos P; Raue F; Hüfner M Clin Chem; 1982 Aug; 28(8):1749-53. PubMed ID: 7094295 [TBL] [Abstract][Full Text] [Related]
10. A novel mechanism for skeletal resistance in uremia. Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099 [TBL] [Abstract][Full Text] [Related]
11. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19. D'Amour P; Brossard JH; Räkel A; Rousseau L; Albert C; Cantor T Clin Chem; 2005 Jan; 51(1):169-76. PubMed ID: 15514090 [TBL] [Abstract][Full Text] [Related]
12. Bioassay of parathyrin: analytical characteristics and clinical performance in patients with hypercalcemia. Klee GG; Preissner CM; Schloegel IW; Kao PC Clin Chem; 1988 Mar; 34(3):482-8. PubMed ID: 2832099 [TBL] [Abstract][Full Text] [Related]
13. Intact parathyroid hormone: performance and clinical utility of an automated assay based on high-performance immunoaffinity chromatography and chemiluminescence detection. Hage DS; Taylor B; Kao PC Clin Chem; 1992 Aug; 38(8 Pt 1):1494-500. PubMed ID: 1643722 [TBL] [Abstract][Full Text] [Related]
14. Clinical performance of parathyroid hormone immunometric assays. Kao PC; van Heerden JA; Grant CS; Klee GG; Khosla S Mayo Clin Proc; 1992 Jul; 67(7):637-45. PubMed ID: 1434896 [TBL] [Abstract][Full Text] [Related]
15. Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone. Curley IR; Wheeler MH; Aston JP; Brown RC; Weeks I; Woodhead JS Surgery; 1987 Dec; 102(6):926-31. PubMed ID: 3686355 [TBL] [Abstract][Full Text] [Related]
16. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. D'Amour P; Brossard JH; Rousseau L; Roy L; Gao P; Cantor T Clin Chem; 2003 Dec; 49(12):2037-44. PubMed ID: 14633875 [TBL] [Abstract][Full Text] [Related]
17. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Nussbaum SR; Zahradnik RJ; Lavigne JR; Brennan GL; Nozawa-Ung K; Kim LY; Keutmann HT; Wang CA; Potts JT; Segre GV Clin Chem; 1987 Aug; 33(8):1364-7. PubMed ID: 3608153 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of C-terminal parathyrin measurement as compared with measurements of N-terminal parathyrin and calcium in serum. Simon M; Cuan J Clin Chem; 1980 Nov; 26(12):1672-6. PubMed ID: 7428150 [TBL] [Abstract][Full Text] [Related]
19. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands. Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003 [TBL] [Abstract][Full Text] [Related]
20. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation. Gao P; D'Amour P Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]